Wells Fargo’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-114,449
Closed -$1.76M 7256
2025
Q4
$1.76M Buy
114,449
+44,459
+64% +$490K ﹤0.01% 3543
2025
Q3
$695K Sell
69,990
-71,441
-51% -$744K ﹤0.01% 4070
2025
Q2
$1.4M Sell
141,431
-44,297
-24% -$467K ﹤0.01% 3485
2025
Q1
$2.41M Buy
185,728
+117,922
+174% +$1.56M ﹤0.01% 3025
2024
Q4
$866K Buy
67,806
+17,230
+34% +$208K ﹤0.01% 3808
2024
Q3
$563K Sell
50,576
-42,378
-46% -$467K ﹤0.01% 3920
2024
Q2
$1.04M Buy
92,954
+50,015
+116% +$582K ﹤0.01% 3467
2024
Q1
$533K Buy
42,939
+3,768
+10% +$49.1K ﹤0.01% 3842
2023
Q4
$548K Sell
39,171
-79,117
-67% -$1.1M ﹤0.01% 3801
2023
Q3
$1.75M Sell
118,288
-19,944
-14% -$281K ﹤0.01% 2911
2023
Q2
$1.79M Buy
138,232
+15,218
+12% +$173K ﹤0.01% 3007
2023
Q1
$1.21M Buy
123,014
+109,725
+826% +$1.17M ﹤0.01% 3249
2022
Q4
$141K Sell
13,289
-6,328
-32% -$73.5K ﹤0.01% 4357
2022
Q3
$205K Sell
19,617
-862
-4% -$11.2K ﹤0.01% 4231
2022
Q2
$258K Sell
20,479
-108,132
-84% -$1.15M ﹤0.01% 4149
2022
Q1
$1.39M Sell
128,611
-30,540
-19% -$371K ﹤0.01% 3611
2021
Q4
$2.24M Sell
159,151
-333,489
-68% -$5.49M ﹤0.01% 3390
2021
Q3
$9.46M Buy
492,640
+323,825
+192% +$4.3M ﹤0.01% 2257
2021
Q2
$1.66M Buy
168,815
+106,872
+173% +$972K ﹤0.01% 3849
2021
Q1
$609K Sell
61,943
-146,302
-70% -$1.21M ﹤0.01% 4583
2020
Q4
$926K Buy
208,245
+2,909
+1% +$13.2K ﹤0.01% 4086
2020
Q3
$887K Buy
205,336
+9,325
+5% +$66.5K ﹤0.01% 3953
2020
Q2
$1.74M Buy
196,011
+146,617
+297% +$741K ﹤0.01% 3365
2020
Q1
$175K Sell
49,394
-10,905
-18% -$50.6K ﹤0.01% 4762
2019
Q4
$345K Sell
60,299
-19,002
-24% -$102K ﹤0.01% 4641
2019
Q3
$284K Buy
79,301
+3,436
+5% +$13.3K ﹤0.01% 4749
2019
Q2
$303K Sell
75,865
-8,286
-10% -$48K ﹤0.01% 4726
2019
Q1
$615K Buy
84,151
+7,492
+10% +$73.2K ﹤0.01% 4205
2018
Q4
$702K Sell
76,659
-11,062
-13% -$122K ﹤0.01% 4109
2018
Q3
$1.09M Buy
87,721
+4,979
+6% +$67.4K ﹤0.01% 3918
2018
Q2
$1.26M Buy
82,742
+37,226
+82% +$644K ﹤0.01% 3820
2018
Q1
$903K Buy
45,516
+3,834
+9% +$66.2K ﹤0.01% 3991
2017
Q4
$779K Sell
41,682
-11,792
-22% -$237K ﹤0.01% 4091
2017
Q3
$1.15M Sell
53,474
-9,169
-15% -$145K ﹤0.01% 3749
2017
Q2
$605K Buy
62,643
+20,900
+50% +$136K ﹤0.01% 4093
2017
Q1
$248K Buy
41,743
+9,634
+30% +$46.3K ﹤0.01% 4685
2016
Q4
$127K Buy
32,109
+17,676
+122% +$129K ﹤0.01% 5025
2016
Q3
$152K Buy
14,433
+563
+4% +$8.09K ﹤0.01% 4641
2016
Q2
$203K Sell
13,870
-2,818
-17% -$48.2K ﹤0.01% 4403
2016
Q1
$321K Buy
16,688
+1,362
+9% +$27.5K ﹤0.01% 4137
2015
Q4
$370K Buy
15,326
+6,952
+83% +$174K ﹤0.01% 4084
2015
Q3
$206K Sell
8,374
-1,308
-14% -$37K ﹤0.01% 4450
2015
Q2
$226K Buy
9,682
+5,760
+147% +$125K ﹤0.01% 4552
2015
Q1
$88K Buy
3,922
+1,253
+47% +$24K ﹤0.01% 4798
2014
Q4
$45K Sell
2,669
-12,442
-82% -$189K ﹤0.01% 5042
2014
Q3
$216K Sell
15,111
-2,133
-12% -$30.7K ﹤0.01% 4321
2014
Q2
$276K Buy
17,244
+15,944
+1,226% +$240K ﹤0.01% 4223
2014
Q1
$23K Sell
1,300
-600
-32% -$11.1K ﹤0.01% 5183
2013
Q4
$38K Buy
1,900
+422
+29% +$6.18K ﹤0.01% 4825
2013
Q3
$18K Buy
1,478
+545
+58% +$6.86K ﹤0.01% 4985
2013
Q2
$10K Buy
+933
New +$19.7K ﹤0.01% 5058

Other funds holding DVAX

Wells Fargo's DVAX Position: Q1 2026 in Review

Wells Fargo sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 114,449 shares — an estimated $1.76M sold.

Wells Fargo first reported a position in DVAX in Q2 2013 and held it in 51 quarters. The position peaked at $9.46M in Q3 2021. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Wells Fargo reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Wells Fargo sold 114,449 Dynavax Technologies shares in Q1 2026, an estimated $1.76M.
  • Wells Fargo first reported a position in Dynavax Technologies in Q2 2013 and held it in 51 quarters.
  • Wells Fargo's Dynavax Technologies position peaked at $9.46M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.